Ginkgo Bioworks Reports Fourth Quarter and Full Year 2022 Financial Results
/PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today...
Source: prnewswire.com